| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0087 | 0.9 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |